0
0
29 words
0
Comments
Regularly monitoring RSV sequences will be critical to ensure that approved mAbs remain effective against circulating strains.
You are the first to view
http://www.pharmaceutical-technology.com/comment/new-rsv-therapies/
Create an account or login to join the discussion